Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)

Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of abnormal lymphocyte survival caused by defective Fas-mediated apoptosis, leading to lymphadenopathy, hepatosplenomegaly, and an increased number of double-negative T cells (DNTs). Treatment options for patients with ALPS are limited. Ra...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Teachey, David T., Obzut, Dana A., Axsom, Kelly, Choi, John K., Goldsmith, Kelly C., Hall, Junior, Hulitt, Jessica, Manno, Catherine S., Maris, John M., Rhodin, Nicholas, Sullivan, Kathleen E., Brown, Valerie I., Grupp, Stephan A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: The American Society of Hematology 2006
Ämnen:
Immunobiology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895548/
https://ncbi.nlm.nih.gov/pubmed/16757690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-01-010124
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk